Pneumonia, which is a lung infection that can cause severe complications and even death, is the most common infection caused by P. aeruginosa. The same strain is responsible for 10% to 20% of all ...

Pseudomonas aeruginosa is one of the most important pathogens considered when treating patients with hospital-acquired pneumonia or ventilator-associated pneumonia. Infections by P. aeruginosa are ...

Sadikot R, Blackwell T, Christman J, Prince A. Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia. American Journal of Respiratory and Critical Care Medicine . June 1, 2005.

Lysine Trimethylation of EF-Tu Mimics Platelet-Activating Factor To Initiate Pseudomonas aeruginosa Pneumonia. mBio , 2013 DOI: 10.1128/mBio.00207-13 Cite This Page : ...

Article: Reappraisal of Pseudomonas aeruginosa hospital-acquired pneumonia mortality in the era of metallo-b-lactamases-mediated multidrug resistance: a prospective observational study." ...

References. 1. Efficacy of panobacumab, an IgM monoclonal antibody, in hospital-acquired pneumonia caused by Pseudomonas aeruginosa (Abstr. 1126) P-F. Laterre et al. Presented at the oral session ...

Pseudomonas aeruginosa is the definition of a tough bacterial strain, ... If it enters lung tissue, for example in a cystic fibrosis patient, it can cause a form of pneumonia.

P. aeruginosa is a highly drug-resistant pathogen. In the drug's pre-clinical trials, it was able to both prevent and treat pneumonia caused by P. aeruginosa in animal models.

A potentially deadly hospital superbug is able to feast on and break down medical-grade plastics—including those used to make implants, sutures and wound dressings.. This is the conclusion of a ...

Similarly, Klebsiella pneumoniae and Pseudomonas aeruginosa also demonstrated rising resistance, particularly to important antibiotics like piperacillin-tazobactam, imipenem, and meropenem.